Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Colorcon
Mallinckrodt
Express Scripts
Boehringer Ingelheim

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tesofensine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Tesofensine?

Tesofensine is an investigational drug.

There have been 10 clinical trials for Tesofensine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2003.

The most common disease conditions in clinical trials are Obesity, Diabetes Mellitus, and Body Weight. The leading clinical trial sponsors are Saniona, NeuroSearch A/S, and Boehringer Ingelheim.

Recent Clinical Trials for Tesofensine
TitleSponsorPhase
48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)SanionaPhase 2
A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart RateSanionaPhase 1
Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)SanionaPhase 2

See all Tesofensine clinical trials

Clinical Trial Summary for Tesofensine

Top disease conditions for Tesofensine
Top clinical trial sponsors for Tesofensine

See all Tesofensine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
AstraZeneca
McKinsey
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.